My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Eli Lilly (NY:LLY)

1,074.93 +3.29 (+0.31%)

Streaming Delayed Price Updated: 12:03 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

99 100 Next >

The Smartest Growth Stock to Buy With $100 Right Now ↗

October 13, 2025

This beaten-down drugmaker is well positioned to turn things around.

Via The Motley Fool

Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? ↗

October 13, 2025

Now may be the time to invest in drug companies, as they just slipped the tariff noose.

Via The Motley Fool

Should You Buy Novo Nordisk Right Now? ↗

October 12, 2025

The fallen pharma giant could make a big comeback in 2026.

Via The Motley Fool

Should Investors Buy Eli Lilly Stock? ↗

October 11, 2025

Investors are excited about the company's weight loss treatments but might be overlooking the exciting pipeline of new therapies.

Via The Motley Fool

MarketBeat Week in Review – 10/06 - 10/10 ↗

October 11, 2025

Investors are eagerly awaiting the start of earnings season for market direction, as the continued government shutdown is creating a lack of economic data

Via MarketBeat

Topics Economy

Smart Money Is Betting Big In LLY Options ↗

October 10, 2025

Via Benzinga

Why Hims & Hers Health (HIMS) Stock Is Nosediving

October 10, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.5% in the afternoon session after a Bank of America report highlighted weakening order trends and a lowered fourth-quarter revenue...

Via StockStory

Topics World Trade

Bill Gates And PAHO Push To Make Weight-Loss Drugs Accessible In Low-Income Nations ↗

October 10, 2025

Bill Gates and PAHO are working to make weight-loss drugs like Wegovy and Mounjaro more affordable for low-income countries.

Via Benzinga

1 Vanguard ETF to Invest In That Can Turn $500 Monthly Into $800,000 ↗

October 10, 2025

This ETF has shown market-beating potential since its inception.

Via The Motley Fool

Topics ETFs

2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now ↗

October 10, 2025

Ongoing developments make these companies look attractive.

Via The Motley Fool

Topics Economy World Trade

Pfizer (NYSE:PFE) Marks 348th Consecutive Dividend Payment: A Pillar of Stability Amidst Transformation

October 09, 2025

New York, NY – October 9, 2025 – Pfizer Inc. (NYSE:PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Eli Lilly Completes Phase 1 Study for Bimagrumab and Tirzepatide Amidst Strategic Pipeline Revisions

October 09, 2025

Eli Lilly and Company (NYSE: LLY) has announced the completion of its Phase 1 bioavailability study for the combination of Bimagrumab and Tirzepatide on October 8, 2025, a foundational step in...

Via MarketMinute

Direxion's QQQU, QQQD ETFs Foster A Diversified Approach To Magnificent 7 Speculation ↗

October 09, 2025

Via Benzinga

Topics ETFs

5 Healthcare Plays Powering the Sector’s Big Comeback ↗

October 09, 2025

After years of lagging, the healthcare sector is showing signs of a turnaround driven by lower rates, policy clarity, and renewed investor interest.

Via MarketBeat

Watch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market ↗

October 09, 2025

Roche has a promising GLP-1 drug that is entering phase 3 trials.

Via The Motley Fool

Amazon's Dual Thrust: Prime Discounts and Pharmacy Expansion Reshape Retail and Healthcare Landscapes

October 08, 2025

Amazon (NASDAQ: AMZN) continues to aggressively expand its strategic business developments, solidifying its e-commerce dominance through frequent Prime discount events and making significant inroads...

Via MarketMinute

Topics Artificial Intelligence Economy

Recent Filing Shows That Rep. David Taylor Bought Over $5K Worth of Procter & Gamble Stock ↗

October 08, 2025

Via Benzinga

Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

October 08, 2025

Via Benzinga

These 2 AI Stocks Could Surpass Oracle in Market Cap by 2030 ↗

October 08, 2025

Investors should buy stakes in AI-powered stocks with scalable, asset-light business models.

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly Stock Eases After-Hours: Ex-FDA Official Ejected By RFK Jr. Joins Firm — Will Investors Warm Up? ↗

October 07, 2025

Investors reacted to the company’s leadership shake-up and new data from its ulcerative colitis therapy Omvoh showing sustained remission over four years.

Via Stocktwits

Topics Government

Healthcare Sector Defies Broader Market Swings, Leads S&P 500 Momentum on October 7, 2025

October 07, 2025

On a day where the broader S&P 500 and Nasdaq Composite indices soared to new all-time record highs, the S&P 500 Healthcare sector presented a compelling, albeit nuanced, narrative of market leadership...

Via MarketMinute

Topics Artificial Intelligence ETFs Intellectual Property

Looking At Eli Lilly's Recent Unusual Options Activity ↗

October 07, 2025

Via Benzinga

Why QuidelOrtho (QDEL) Stock Is Down Today

October 07, 2025

Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 4.4% in the morning session after Citigroup analyst Patrick Donnelly downgraded the stock to 'Neutral' from 'Buy' and lowered the...

Via StockStory

Topics World Trade

Long-Term Study Shows Sustained Remission With Eli Lilly's Ulcerative Colitis Drug ↗

October 07, 2025

Eli Lilly's four-year LUCENT-3 study shows Omvoh maintained high remission rates and a consistent safety profile in ulcerative colitis patients.

Via Benzinga

Where Will LLY Be in 5 Years? ↗

October 07, 2025

After nearly two years of sideways price action, Eli Lilly stock could soar to new highs between now and 2030.

Via The Motley Fool

Topics World Trade

Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal ↗

October 06, 2025

Eli Lilly just got great news, courtesy of Pfizer and Trump, leading shares to their highest level in five months. Its rally may just be getting started.

Via MarketBeat

Topics Government World Trade

$1000 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today ↗

October 06, 2025

Via Benzinga

Eli Lilly Eyes India For Manufacturing, Plans To Spend $1 Billion ↗

October 06, 2025

Eli Lilly plans over $1 billion investment in India to expand drug manufacturing, partnerships, and a new Hyderabad facility.

Via Benzinga

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants ↗

October 06, 2025

Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief.

Via MarketBeat

Topics Government Supply Chain World Trade

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.